Advasa Holdings, Inc. (ADBT) · Oct 27, 2026 · Delisting

Advasa Nasdaq warning gives it 180 days to fix sub-$1 shares

Nasdaq listing deficiency — Below $1.00 minimum bid price for 30 consecutive business days; cure deadline April 19, 2027

Advasa received a Nasdaq deficiency notice after 30 straight business days below the $1 bid-price rule, starting a 180-day cure period.

Advasa is a newly public fintech building an earned-wage-access and payroll-payment platform through its Japanese subsidiary, with ambitions to expand its Payroll DX and payment infrastructure internationally. The immediate issue is listing compliance, not operating performance. Nasdaq says Advasa’s closing bid price stayed below the $1.00 minimum for 30 consecutive business days.

ItemFiling detail
Nasdaq cure period180 calendar days
Compliance deadlineApril 19, 2027
Required trading performanceAt least $1.00 bid price for 10 consecutive business days
TriggerBelow $1.00 for 30 consecutive business days

The notice creates a real but not immediate delisting risk. Advasa has until April 19, 2027 to regain compliance, and Nasdaq can confirm compliance if the stock meets the threshold for at least 10 consecutive business days. 〔0〕

A lower-tier transfer is the fallback, not a clean resolution. If Advasa cannot cure the deficiency by the deadline, it may seek transfer to the Nasdaq Capital Market if it satisfies the other listing requirements; otherwise, Nasdaq could issue a delisting determination that Advasa could appeal. 〔1〕

The filing offers no operating fix or concrete remediation plan. Management says it will monitor the bid price and consider available options, but it does not disclose a reverse split, capital action, or other identified measure that would restore compliance. 〔2〕

Bottom line: This is a newly disclosed capital-markets problem layered onto a recently listed growth story. The company has substantial time to cure it, but the filing adds a clear delisting overhang without yet showing how management intends to remove it.

What to watch next

Regain $1 bid price by April 19, 2027

Original filing on SEC EDGAR

More Advasa Holdings, Inc. news

Advasa Nasdaq warning gives it 180 days to fix sub-$1 shares | ADBT Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.